Loxam Teri — SEC Form 4 filings
SEC reporting owner CIK 1829111. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-05 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 2 filings — 12,500 shares, $1,258,694 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 4,308 shares @ $116.62 ($502,387) in Vaxcyte, Inc., filed 2024-09-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | Director | 5 | — | 12 legs · 12,500 sh · $1,258,694 | 10 |
| COMPASS Pathways plc (CMPS) | Chief Financial Officer | 6 | — | — | 9 |
Form 4 filings — Loxam Teri
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 75,000 @ $0 · Grant/award (A): 157,635 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | COMPASS Pathways plc (CMPS) | Tax withholding (F): 1,781 @ $6.89 | EDGAR |
| 2026-03-03 | 4 | COMPASS Pathways plc (CMPS) | Tax withholding (F): 4,467 @ $7.02 | EDGAR |
| 2025-06-16 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 3,041 @ $0 · Grant/award (A): 15,372 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 25,000 @ $0 · Grant/award (A): 76,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | COMPASS Pathways plc (CMPS) | Tax withholding (F): 4,468 @ $3.67 | EDGAR |
| 2025-01-17 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 6,250 @ $22.70 · Sale (S): 146 @ $80.46 · Sale (S): 215 @ $81.53 · Sale (S): 1,136 @ $82.89 · Sale (S): 1,202 @ $83.93 · Sale (S): 1,043 @ $85.29 · +4 more | EDGAR |
| 2024-09-18 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 6,250 @ $22.70 · Sale (S): 241 @ $114.64 · Sale (S): 1,445 @ $115.32 · Sale (S): 4,308 @ $116.62 · Sale (S): 256 @ $117.51 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 1,550 @ $0 · Grant/award (A): 7,250 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | COMPASS Pathways plc (CMPS) | Grant/award (A): 62,718 @ $0 · Grant/award (A): 117,643 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1829111 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →